Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Tamir Mosharrafa

Plastic and Reconstructive Surgery Phoenix, AZ Medical Doctor

NPI 1801832977 CMS profile 172311

4611 E Shea Blvd Ste 230, Phoenix, AZ 85028

Open in the dashboard

General payments

$159,705

187 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$50,476 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Tamir Mosharrafa of Phoenix, AZ is reported in the CMS Open Payments database as having received $159,705 across 187 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $50,476 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $78,043 53
2024 General $48,334 37
2023 General $13,047 21
2022 General $9,124 17
2021 General $415 14
2020 General $1,221 15
2019 General $9,521 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tamir Mosharrafa
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Tamir Mosharrafa were reported at $78,043. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Tamir Mosharrafa Plastic and Reconstructive Surgery median Middle half National median
2019 $9,521 $335 $121–$1,264 $163
2020 $1,221 $162 $57–$417 $114
2021 $415 $245 $89–$735 $132
2022 $9,124 $325 $120–$932 $149
2023 $13,047 $343 $129–$999 $160
2024 $48,334 $390 $141–$1,085 $164
2025 $78,043 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Mentor Worldwide LLC $83,056 108 payments
  2. Medical Device Business Services, Inc. $75,523 37 payments
  3. Allergan Inc. $370 21 payments
  4. Musculoskeletal Transplant Foundation Inc. $190 4 payments
  5. AbbVie, Inc. $164 6 payments
  6. TELA Bio, Inc. $144 3 payments
  7. Tepha Inc $87 1 payment
  8. Apyx Medical Corporation $51 1 payment
  9. Pacira Pharmaceuticals Incorporated $45 2 payments
  10. Boston Scientific Corporation $28 2 payments
  11. Other $48 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $136,750 35 payments
  2. Travel and Lodging $13,981 38 payments
  3. Food and Beverage $4,774 113 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,200 1 payment
Products named General payments · program years 2019–2025
  1. MENTOR MemoryGel Resterilizable Gel Sizer $20,063 48 payments
  2. MENTOR CPX 2 Breast Tissue Expander $9,697 11 payments
  3. MENTOR MemoryShape Breast Implant $6,115 6 payments
  4. MemoryGel Breast Implants $4,200 14 payments
  5. ARTOURA Breast Tissue Expander Plastic Surgery $3,917 8 payments
  6. MemoryShape Breast Implants $3,628 5 payments
  7. ARTOURA Breast Tissue Expander Plastic Surgery $380 7 payments
  8. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $118 7 payments
  9. BOTOX $109 4 payments
  10. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $91 4 payments
  11. Other $573 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

89

Median for Plastic and Reconstructive Surgery: 61

Drug cost

$540

Median for Plastic and Reconstructive Surgery: $369

Branded share of claims

59.6%

Median for Plastic and Reconstructive Surgery: 30%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 27 $241
Ondansetron Odt Ondansetron Brand 26 $151
Cephalexin Generic 36 $148

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,638 Part D prescribers listed as Plastic and Reconstructive Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 24 billing codes

Paid by Medicare

$21,835

Medicare's payments for the services billed

Medicare patients

47

Average age 71

Services billed

108

47 women, 0 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Cancer 75%
Arthritis 55%
High blood pressure 43%
Osteoporosis 28%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

187 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record